User: Genecampaign Topic: IP
Category: patents :: everywhere
Last updated: May 17 2013 17:33 IST RSS 2.0
 
7,454 to 7,473 of 8,510    
Dwijen Rangnekar: Who is the real pariah? (Cached) 15.9.2007 Business Standard
Dwijen Rangnekar: Who is the real pariah?
Also found in: [+]
LexisNexis publications launched (Cached) 15.9.2007 Hindu: Tamil Nadu
CHENNAI: LexisNexis ( www.lexisnexis.com ), a provider of information and services solutions, recently launched two publications: ‘The Law of Patents – With a Special Focus on Pharmaceuticals ...
Also found in: [+]
P&G asks judge to stop Kraft from using coffee container (Cached) 15.9.2007 TOI: Intl Business
Procter & Gamble asked a judge to stop Kraft Foods from continuing to manufacture its coffee in a plastic container that it alleged infringes on a patent.
Also found in: [+]
Setback to Dr Reddys in US case (Cached) 14.9.2007 Financial Express: Front Page
In what could be termed as a setback to the Indian drug major, Dr Reddy's Labs has reached at an out-of-court settlement with Teva Pharmaceuticals in patent litigation regarding the sales of blockbuster anti-depressant drug, Zoloft.
Also found in: [+]
Ranbaxy loses battle for Lipitor patent in Canada (Cached) 14.9.2007 ET: Pharma
In a setback for Ranbaxy in its global battle over the patent of Lipitor, a Canadian federal court has ruled that the company’s generic drug Atorvastatin infringes upon one of Pfizer’s Lipitor patent.
Also found in: [+]
Favourable ruling lifts Lupin (Cached) 14.9.2007 HBL: Markets
Early launch crucial
Also found in: [+]
Pfizer is one up on Ranbaxy in battle over Lipitor patent (Cached) 13.9.2007 Financial Express: Front Page
In a partial setback for Indian pharma major Ranbaxy Laboratories Ltd's in its ongoing courtroom battle with pharma giant Pfizer over cholesterol-lowering drug Lipitor, a Canadian High Court said that it infringed the latter's patent covering a crystalline form of atorvastatin, which is used as the active ingredient in the blockbuster drug.
Also found in: [+]
Lupin wins challenge for blood pressure drug (Cached) 13.9.2007 Business Standard
Lupin wins challenge for blood pressure drug
Also found in: [+]
Canadian court favours Ranbaxy in Lipitor case (Cached) 13.9.2007 Business Standard
Canadian court favours Ranbaxy in Lipitor case
Also found in: [+]
Lupin wins patent case on BP drug (Cached) 13.9.2007 Financial Express
Lupin wins patent case on BP drug
Also found in: [+]
Partial setback for Ranbaxy in Lipitor case in Canada (Cached) 13.9.2007 ET: Pharma
A Canadian court has ruled that Ranbaxy Laboratories has infringed one of the US pharma major's patent.
Also found in: [+]
Lupin wins Altace patent case in US (Cached) 13.9.2007 ET: Pharma
India’s Lupin has won its patent challenge against King Pharmaceuticals and Sanofi-Aventis for blood pressure drug Altace, which has sales of $700 million in the US alone.
Also found in: [+]
Avesthagen gets Australian patent (Cached) 13.9.2007 Hindu: Business
Technology opens up more crops for hybrid seed production
Also found in: [+]
Riding on Innovation (Cached) 13.9.2007 TOI: Editorial
Securing two-wheeler market demands continuous improvement.
Also found in: [+]
Anthropological data to be used for personalised medicine (Cached) 12.9.2007 Express India-- Front Page
Anthropological data is being used to formulate personalised medicine based on DNA for treatment of complex diseases
Also found in: [+]
Sun Pharma gets US 180-day exclusivity (Cached) 12.9.2007 Business Standard
Sun Pharma gets US 180-day exclusivity
Also found in: [+]
Sepracor spanner in Sun Pharma's US plan (Cached) 11.9.2007 ET: Pharma
US-based drug giant Sepracor Inc and the University of Massachusetts have filed a patent infringement suit with the US district court of New Jersey against Sun Pharmaceutical Industries, to prevent the Indian drug maker from selling a generic version of Sepracor’s drug desloratadine, branded Clarinex.
Also found in: [+]
HC to hear Novartis case on October 8 (Cached) 11.9.2007 ET: Pharma
The Madras High Court will hear on October 8, Novartis' objection to the appointment of S Chandrasekaran, former Controller General of the Indian Patent Office, to consider its appeal against the rejection of patent for its anti-cancer drug Glivec.
Also found in: [+]
Ranbaxy plans local buyouts (Cached) 10.9.2007 Business Standard
Ranbaxy plans local buyouts
Also found in: [+]
Bajaj launches new bike (Cached) 10.9.2007 The Statesman
Bajaj launches new bike
Also found in: [+]
7,454 to 7,473 of 8,510